Hydroxychloroquine suppresses interferon-inducible genes and B-cell activating factor in patients with incomplete and new onset systemic lupus erythematosus

Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. This study was funded by ReumaNederland/ Dutch Arthritis Foundation. Correspondence address: Wietske M. Lambers, MD, PhD Candidate, Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands. E-mail: w.m.lambers@umcg.nl

Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. This study was funded by ReumaNederland/ Dutch Arthritis Foundation. Correspondence address: Wietske M. Lambers, MD, PhD Candidate, Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands. E-mail: w.m.lambers@umcg.nl

Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. This study was funded by ReumaNederland/ Dutch Arthritis Foundation. Correspondence address: Wietske M. Lambers, MD, PhD Candidate, Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands. E-mail: w.m.lambers@umcg.nl

Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. This study was funded by ReumaNederland/ Dutch Arthritis Foundation. Correspondence address: Wietske M. Lambers, MD, PhD Candidate, Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, Hanzeplein 1, 9700 RB Groningen, The Netherlands. E-mail: w.m.lambers@umcg.nl